Atria Investments Inc Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Atria Investments Inc bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 6,799 shares of the company’s stock, valued at approximately $213,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in OPCH. UMB Bank n.a. grew its stake in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after buying an additional 750 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. raised its position in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. lifted its stake in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares during the period. Finally, International Assets Investment Management LLC boosted its stake in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Finally, Barrington Research dropped their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Price Performance

Option Care Health stock opened at $23.13 on Friday. The firm has a 50-day moving average price of $27.62 and a 200-day moving average price of $29.10. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $3.94 billion, a PE ratio of 19.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.